Identity
- Security key
- 11201
- Ticker
- ABSI
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-07-22
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ABSI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,630,333,095
- Shares outstanding (class)
- 155,905,056
- Shares outstanding (weighted)
- 171,614,010
- SIC
- 8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Employees
- 140
- Location
- VANCOUVER, WA
- Homepage
- https://www.absci.com
- Description
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.